Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

The overarching aim of this study was to provide an exploratory, nutrient-specific systematic review and meta-analysis of evidence linking vitamin D and vitamin B12 to clinically relevant psychiatric outcomes.

Source: 1.2. Objectives and Research Questions (Including Exploratory Subgroup Questions). View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Systematic review.

Systematic review

Uses explicit methods to identify, assess and summarise research on a defined question.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Vitamin D and Vitamin B12 in Psychiatric Disorders: An Exploratory Systematic Review and Meta-Analysis of Nutrient-Specific Status and Supplementation Evidence

Source: Article title.

Vitamin D and Vitamin B12 in Psychiatric Disorders: An Exploratory Systematic Review and Meta-Analysis of Nutrient-Specific Status and Supplementation Evidence

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D and Vitamin B12 in Psychiatric Disorders: An Exploratory Systematic Review and Meta-Analysis of Nutrient-Specific Status and Supplementation Evidence

Systematic review · Diseases · 2026

Original publication title

Vitamin D and Vitamin B12 in Psychiatric Disorders: An Exploratory Systematic Review and Meta-Analysis of Nutrient-Specific Status and Supplementation Evidence

Lavinia-Alexandra Moroianu; Cecilia Curis; Valeriu Ardeleanu; Roxana Elena Bogdan-Goroftei; Simona-Dana Mitincu-Caramfil; Marius Moroianu; Alina Pleșea-Condratovici

© 2026 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Background/Objectives: Evidence linking vitamins D and B12 to psychiatric outcomes remains heterogeneous across designs, populations, phenotypes, exposures, and outcome formats. Methods: We conducted a PRISMA 2020 systematic review and exploratory meta-analysis of nutrient-specific status and supplementation evidence. PubMed/MEDLINE, APA PsycInfo, Cochrane Library, Google Scholar, ClinicalTrials.gov, and ProQuest were searched for human studies published in 2016 to 2025, with a final update on 1 March 2026. Forty-six studies were included (24 randomized controlled trials, 22 observational studies; N = 69,902), and 44 contributed quantitative data.

Effects were harmonized to odds ratios (ORs) for cross-family comparability and pooled using Hartung: Knapp random-effects models; supplementation evidence was additionally interpreted on the standardized mean difference (SMD) scale. Results: Across the main evidence families, pooled estimates showed substantial heterogeneity and limited generalizability. Vitamin D supplementation showed an initial inverse estimate on the secondary harmonized OR scale (OR = 0.439, 95% CI 0.272 to 0.710) and a clinically interpretable SMD of −0.454 (95% CI −0.718 to −0.189), but heterogeneity was high (I2 = 84.2%) and trim-and-fill attenuated the OR estimate to the null (OR = 0.88, 95% CI 0.48 to 1.63).

Vitamin D status showed a similar pattern (primary OR = 0.615, 95% CI 0.424 to 0.890; trim-and-fill OR = 0.90, 95% CI 0.54 to 1.49). Vitamin B12 status was inversely associated with outcomes (OR = 0.310, 95% CI 0.115 to 0.834), but heterogeneity was extreme (I2 = 94.8%). B12 supplementation evidence was sparse and null. Conclusions: The evidence supports targeted deficiency assessment, not routine supplementation.

Authors’ abstract

Background/Objectives: Evidence linking vitamins D and B12 to psychiatric outcomes remains heterogeneous across designs, populations, phenotypes, exposures, and outcome formats. Methods: We conducted a PRISMA 2020 systematic review and exploratory meta-analysis of nutrient-specific status and supplementation evidence. PubMed/MEDLINE, APA PsycInfo, Cochrane Library, Google Scholar, ClinicalTrials.gov, and ProQuest were searched for human studies published in 2016 to 2025, with a final update on 1 March 2026. Forty-six studies were included (24 randomized controlled trials, 22 observational studies; N = 69,902), and 44 contributed quantitative data.

Effects were harmonized to odds ratios (ORs) for cross-family comparability and pooled using Hartung: Knapp random-effects models; supplementation evidence was additionally interpreted on the standardized mean difference (SMD) scale. Results: Across the main evidence families, pooled estimates showed substantial heterogeneity and limited generalizability. Vitamin D supplementation showed an initial inverse estimate on the secondary harmonized OR scale (OR = 0.439, 95% CI 0.272 to 0.710) and a clinically interpretable SMD of −0.454 (95% CI −0.718 to −0.189), but heterogeneity was high (I2 = 84.2%) and trim-and-fill attenuated the OR estimate to the null (OR = 0.88, 95% CI 0.48 to 1.63).

Vitamin D status showed a similar pattern (primary OR = 0.615, 95% CI 0.424 to 0.890; trim-and-fill OR = 0.90, 95% CI 0.54 to 1.49). Vitamin B12 status was inversely associated with outcomes (OR = 0.310, 95% CI 0.115 to 0.834), but heterogeneity was extreme (I2 = 94.8%). B12 supplementation evidence was sparse and null. Conclusions: The evidence supports targeted deficiency assessment, not routine supplementation.

Publication and source details

Original title: Vitamin D and Vitamin B12 in Psychiatric Disorders: An Exploratory Systematic Review and Meta-Analysis of Nutrient-Specific Status and Supplementation Evidence

Lavinia-Alexandra Moroianu; Cecilia Curis; Valeriu Ardeleanu; Roxana Elena Bogdan-Goroftei; Simona-Dana Mitincu-Caramfil; Marius Moroianu; Alina Pleșea-Condratovici

Diseases · 2026

* Correspondence: valeriu.ardeleanu@gmail.com (V.A.); roxana.goroftei@ugal.ro (R.E.B.-G.)
†

These authors contributed equally to this work.

© 2026 by the authors.2026https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.This research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T10:36:38.695538+00:00

DOI: 10.3390/diseases14050167 · PMC13206110